Skip to main content

Latest stock market podcasts

From the helm: Proteomics International (ASX:PIQ), Dr. Richard Lipscombe, Managing Director

Bell Direct
July 7, 2025

In this episode of From the helm, Bell Financial Group’s Grady Wulff speaks with Proteomics International Laboratories (ASX: PIQ) CEO, Dr. Richard Lipscombe, about the company’s ground breaking work in predictive diagnostics and the global opportunity for its world-first blood tests.

In this video, Dr. Lipscombe covers:
·      (0:47): An overview of PIQ and its FY26 goals
·      (1:38): The significance of three world-first blood tests
·      (5:26): The global addressable markets for these conditions
·      (6:25): Clinical trial progress and commercialisation roadmap
·      (8:14): How the diagnostic tests work and deliver value to patients
·      (9:16): Commercialisation strategy across key regions
·      (11:23): Additional assets in the PIQ pipeline
·      (12:36): What investors can expect over the next 12 months

Note: This interview was recorded on 3 July 2025.

Weekly Wrap 22 August

Bell Direct
August 22, 2025

Morning Bell 21 August

Bell Direct
August 21, 2025

Reporting Season August 2025 – Week 3

Bell Direct
August 20, 2025

Morning Bell 20 August

Bell Direct
August 20, 2025

Morning Bell 19 August

Bell Direct
August 19, 2025

Morning Bell 18 August

Bell Direct
August 18, 2025

Morning Bell 14 August

Bell Direct
August 14, 2025

Morning Bell 13 August

Bell Direct
August 13, 2025

Morning Bell 12 August

Bell Direct
August 12, 2025

Morning Bell 11 August

Bell Direct
August 11, 2025

Morning Bell 7 August

Bell Direct
August 7, 2025